STAT+: Pharmalittle: Pfizer CEO rallies employees to fight drug-price negotiations; Glaxo head pressured by another activist fund

GlaxoSmithKline CEO Emma Walmsley has come under pressure from a second activist hedge fund, which has taken a stake worth about $14 million to push for change at the top.

Click to view original post